152 related articles for article (PubMed ID: 31734783)
1. TOPKi-NBD: a fluorescent small molecule for tumor imaging.
Pirovano G; Roberts S; Reiner T
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):1003-1010. PubMed ID: 31734783
[TBL] [Abstract][Full Text] [Related]
2. T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer.
Ikeda Y; Park JH; Miyamoto T; Takamatsu N; Kato T; Iwasa A; Okabe S; Imai Y; Fujiwara K; Nakamura Y; Hasegawa K
Clin Cancer Res; 2016 Dec; 22(24):6110-6117. PubMed ID: 27334838
[TBL] [Abstract][Full Text] [Related]
3. [
Pirovano G; Roberts S; Brand C; Donabedian PL; Mason C; de Souza PD; Higgins GS; Reiner T
Mol Imaging Biol; 2019 Aug; 21(4):705-712. PubMed ID: 30357568
[TBL] [Abstract][Full Text] [Related]
4. Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models.
Stefka AT; Johnson D; Rosebeck S; Park JH; Nakamura Y; Jakubowiak AJ
Cancer Med; 2020 Jan; 9(1):324-334. PubMed ID: 31714026
[TBL] [Abstract][Full Text] [Related]
5. T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma.
Thanindratarn P; Dean DC; Nelson SD; Hornicek FJ; Duan Z
Cell Prolif; 2020 Oct; 53(10):e12901. PubMed ID: 32960500
[TBL] [Abstract][Full Text] [Related]
6. TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer.
Park JH; Inoue H; Kato T; Zewde M; Miyamoto T; Matsuo Y; Salgia R; Nakamura Y
Cancer Sci; 2017 Mar; 108(3):488-496. PubMed ID: 28075524
[TBL] [Abstract][Full Text] [Related]
7. Cell growth inhibition by 3-deoxysappanchalcone is mediated by directly targeting the TOPK signaling pathway in colon cancer.
Zhao R; Huang H; Choi BY; Liu X; Zhang M; Zhou S; Song M; Yin F; Chen H; Shim JH; Bode AM; Dong Z; Lee MH
Phytomedicine; 2019 Aug; 61():152813. PubMed ID: 31035049
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells.
Kato T; Inoue H; Imoto S; Tamada Y; Miyamoto T; Matsuo Y; Nakamura Y; Park JH
Oncotarget; 2016 Apr; 7(14):17652-64. PubMed ID: 26933922
[TBL] [Abstract][Full Text] [Related]
9. Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T-lymphokine-activated killer cell-originated protein kinase.
Zhao R; Choi BY; Wei L; Fredimoses M; Yin F; Fu X; Chen H; Liu K; Kundu JK; Dong Z; Lee MH
Br J Pharmacol; 2020 May; 177(10):2303-2319. PubMed ID: 31985814
[TBL] [Abstract][Full Text] [Related]
10. Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase.
Zeng X; Liu L; Zheng M; Sun H; Xiao J; Lu T; Huang G; Chen P; Zhang J; Zhu F; Li H; Duan Q
Oncotarget; 2016 Apr; 7(16):22460-73. PubMed ID: 26967058
[TBL] [Abstract][Full Text] [Related]
11. T-LAK cell-originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma.
Thanindratarn P; Wei R; Dean DC; Singh A; Federman N; Nelson SD; Hornicek FJ; Duan Z
Mol Oncol; 2021 Dec; 15(12):3721-3737. PubMed ID: 34115928
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells.
Zhu F; Zykova TA; Kang BS; Wang Z; Ebeling MC; Abe Y; Ma WY; Bode AM; Dong Z
Gastroenterology; 2007 Jul; 133(1):219-31. PubMed ID: 17631144
[TBL] [Abstract][Full Text] [Related]
13. The T-LAK Cell-originated Protein Kinase Signal Pathway Promotes Colorectal Cancer Metastasis.
Zykova TA; Zhu F; Wang L; Li H; Bai R; Lim DY; Yao K; Bode AM; Dong Z
EBioMedicine; 2017 Apr; 18():73-82. PubMed ID: 28412249
[TBL] [Abstract][Full Text] [Related]
14. Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis.
Gao T; Hu Q; Hu X; Lei Q; Feng Z; Yu X; Peng C; Song X; He H; Xu Y; Zuo W; Zeng J; Liu Z; Yu L
Cancer Lett; 2019 Mar; 445():11-23. PubMed ID: 30590102
[TBL] [Abstract][Full Text] [Related]
15. Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth.
Kim DJ; Li Y; Reddy K; Lee MH; Kim MO; Cho YY; Lee SY; Kim JE; Bode AM; Dong Z
Cancer Res; 2012 Jun; 72(12):3060-8. PubMed ID: 22523035
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel 1-phenyl phenanthridin-6(5H)-one derivatives as anti-tumor agents targeting TOPK.
Hu QF; Gao TT; Shi YJ; Lei Q; Liu ZH; Feng Q; Chen ZJ; Yu LT
Eur J Med Chem; 2019 Jan; 162():407-422. PubMed ID: 30453248
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitor ilaprazole suppresses cancer growth by targeting T-cell-originated protein kinase.
Zheng M; Luan S; Gao S; Cheng L; Hao B; Li J; Chen Y; Hou X; Chen L; Li H
Oncotarget; 2017 Jun; 8(24):39143-39153. PubMed ID: 28388576
[TBL] [Abstract][Full Text] [Related]
18. Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase.
Diao X; Yang D; Chen Y; Liu W
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898980
[TBL] [Abstract][Full Text] [Related]
19. T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia.
Alachkar H; Mutonga M; Malnassy G; Park JH; Fulton N; Woods A; Meng L; Kline J; Raca G; Odenike O; Takamatsu N; Miyamoto T; Matsuo Y; Stock W; Nakamura Y
Oncotarget; 2015 Oct; 6(32):33410-25. PubMed ID: 26450903
[TBL] [Abstract][Full Text] [Related]
20. Xanthohumol inhibits non-small cell lung cancer via directly targeting T-lymphokine-activated killer cell-originated protein kinase.
Zhao S; Cui J; Cao L; Han K; Ma X; Chen H; Yin S; Zhao C; Ma C; Hu H
Phytother Res; 2023 Jul; 37(7):3057-3068. PubMed ID: 36882184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]